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Abstract: Improper diet can alter gene expression by breaking the energy balance equation and
changing metabolic and oxidative stress biomarkers, which can result in the development of
obesity-related metabolic disorders. The pleiotropic effects of dietary plant polyphenols are capable
of counteracting by modulating different key molecular targets at the cell, as well as through
epigenetic modifications. Hibiscus sabdariffa (HS)-derived polyphenols are known to ameliorate
various obesity-related conditions. Recent evidence leads to propose the complex nature of the
underlying mechanism of action. This multi-targeted mechanism includes the regulation of energy
metabolism, oxidative stress and inflammatory pathways, transcription factors, hormones and
peptides, digestive enzymes, as well as epigenetic modifications. This article reviews the accumulated
evidence on the multiple anti-obesity effects of HS polyphenols in cell and animal models, as well
as in humans, and its putative molecular targets. In silico studies reveal the capacity of several HS
polyphenols to act as putative ligands for different digestive and metabolic enzymes, which may also
deserve further attention. Therefore, a global approach including integrated and networked omics
techniques, virtual screening and epigenetic analysis is necessary to fully understand the molecular
mechanisms of HS polyphenols and metabolites involved, as well as their possible implications in
the design of safe and effective polyphenolic formulations for obesity.
Keywords: antioxidants; dietary supplementation; obesity; epigenetics; metabolic stress; polyphenols;
metabolites; virtual screening; Hibiscus sabdariffa
1. Introduction
Diet-induced obesity and a sedentary lifestyle are consistent with the appearance of several
metabolic dysfunctions leading to metabolic syndrome (MetS). MetS is a clustering of cardio-metabolic
risk factors, including abdominal obesity, insulin resistance, dyslipidemia and hypertension [1,2].
Although considerable progress has been made in understanding the molecular mechanisms
underlying obesity, in many cases its treatment results in failure [3]. In this respect, caloric restriction
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and physical activity are the primary approaches prescribed to improve an individual´s metabolism.
However, in the majority of cases, this is very difficult to maintain for a prolonged period, as it
implicates important changes in the individual´s lifestyle [4,5]. Likewise, current anti-obesity
pharmacological treatments are in many cases inefficient, and often present important side effects
when taken for a prolonged period [6–8]. For this reason, many researchers and clinicians have
drawn their attention towards more traditional methods to correct the obesity-induced energy
imbalance. Accordingly, the use of metabolic drugs or natural dietary products, including polyphenolic
xenohormetins, are some of the most interesting and promising strategies in forthcoming studies
addressing obesity [9,10]. Exploring the effects of polyphenols on specific cellular pathways and
diseases may turn the preventive use of natural agents into a dietary intervention in the treatment
of chronic metabolic diseases. The multifactorial nature of polyphenols, a plausible consequence of
their molecular diversity, offers a new opportunity to address obesity [11–16]. To this end, the main
objective of this review is to elucidate the putative molecular targets of Hibiscus sabdariffa (HS) L.
(Malvaceae) polyphenols and provide an overview of their role in the prevention of chronic diseases
such as obesity.
In this review, we have collected all the relevant evidence regarding the possible benefits
of polyphenolic extracts derived from HS calyces on the management of obesity-related
pathologies [17–22]. These studies include the use of cell and animal obesity models, as well as human
clinical trials. Furthermore, the complete characterization of this plant extract, its effective dosage,
synergistic effects, bioavailability, in silico approach on selected molecular targets and localization
of bioactive metabolites in tissues have been reviewed. The aim of this review is to provide a
comprehensive examination clarifying whether the proper use of HS polyphenols may present an
opportunity to improve the control or prevention of obesity-related diseases through the modulation
of key proteins involved in oxidative stress and inflammation and, consequently, in the regulation of
metabolic and bioenergetics pathways.
In this respect, recent data have shown that AMP-activated protein kinase (AMPK) and
peroxisome proliferator-activated receptors (PPAR), among others, may be possible molecular targets
for HS polyphenols, as evidenced in cellular and animal models [21,23,24]. This hypothesis suggests
that the active manipulation of energy sensors and effectors in obesity might be a feasible preventive
therapy. Nevertheless, further research is necessary in order to delimit all the protein targets that
are modulated by HS polyphenols and to elucidate their molecular mechanisms. For this purpose,
metabolic profiling through “Omics” science must be used to identify the final intracellular metabolites
derived from HS polyphenols that reach intracellular targets, as well as to identify endogenous
metabolite biomarkers. From this perspective, validated obesity-related biomarkers could provide
new diagnostic tools and establish key insights concerning the effects of natural compounds on the
pathogenesis of energy-related complications.
2. Hibiscus sabdariffa Polyphenols as Xenohormetic Agents
“Let food be thy medicine and medicine be thy food” quoted by Hippocrates, and its more
modern analog “an apple a day keeps the doctor away” both reflect the implicitness of food on health.
Plants that traditionally served as food, fuel, water and fiber, are now being engineered as a source
of natural bioactive compounds with particular attention focused on nutraceutical products and
functional foods. This has in turn given rise to the concept of xenohormesis, or molecular networking
between species, which tries to explain the multiple positive effects of plant-derived polyphenols on
human health [25,26]. This consists in the idea that our body reacts to the signals that plants generate
in periods of stress. In this sense, these biochemical signals, called xenohormetins, fulfill important
metabolic and defensive functions in plants, such as protection against UV radiation and pathogen
infection, nodulation, hormone transportation, as well as several other functions such as defense
against herbivorism or pollination [27]. The induction of protective secondary metabolites, especially
phenolics, allows plants to withstand the effect of environmental stressors, as a self-defense mechanism
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against external conditions [28]. Thus, this complex mechanism to protect themselves and improved
throughout evolution can be in part extrapolated to humans through plant food consumption [9,29],
challenging their own genetic inheritance by modifying innate responses [10].
Several thousand of these safe xenohormetic molecules have already been identified from a
multitude of plant species [30]. Plants increase the synthesis of secondary metabolites upon aggressive
conditions [31,32]. However, the expected amount of polyphenols in vegetables and fruits for human
consumption is low and its bioavailability is limited [33]. A successful strategy to increase the intake of
polyphenols would be using products derived from exotic or medicinal plants that may represent an
important source of polyphenols, as well as through the proper extraction procedure and enrichment
techniques [34–36]. Among various medicinal plants studied, HS represents a potentially optimal
source of bioactive molecules for the treatment of various diseases [17,20,21,37–39].
In this respect, anthocyanins are one of the major polyphenolic compounds in HS aqueous
extracts, and are responsible for the bright red color of the flowers. Anthocyanins in HS such as
delphinidin-sambubioside (red pigment) and cyanidin-sambubioside (pink pigment) comprise the
predominant anthocyanin compounds of the extract (Figure 1) and can be used as an alternative to
the synthetic dyes used in the food industry [40,41]. Due to their remarkable in vitro antioxidant
capability, anthocyanins have received increasing attention in the past two decades [42–44], and is
generally accepted that anthocyanins may substantially contribute to the protective effects of HS. In fact,
a correlation has been established between the antioxidant activity of HS materials and anthocyanin
content, suggesting that these compounds may significantly contribute to HS´s antioxidant effect [45].
Nevertheless, extrapolation of the in vitro antioxidant properties of anthocyanins to an in vivo situation
may be difficult, since these compounds are highly soluble in water and have a very short half-life, i.e.,
are poorly bioavailable and quite possibly not capable of reaching their molecular targets at a sufficient
concentration to exert a notable effect [46]. Therefore, this suggests that the biological effect of HS
extracts is not exclusively due to these antioxidant compounds. On the other hand, many studies have
indicated that polyphenols present a wide variety of effects, supporting the fact that these compounds
reach multiple molecular targets and exhibit molecular promiscuity [47,48], which might also endorse
the xenohormesis hypothesis. In fact, HS polyphenols have recently been proposed as modulators of
gene expression [21] and may be involved in several pathways related to chronic inflammation and
energy metabolism [17,23,49]. Consequently, it seems necessary to discern whether the health benefits
attributed to HS polyphenols are mainly due to their antioxidant effect or to their ability to modulate
the activity of different target proteins, possibly through a synergic mechanism.




Figure 1. Chemical structures (explicit hydrogens have been eliminated) of the major compounds
identified in Hibiscus sabdariffa extracts by liquid chromatography coupled to high resolution mass
spectrometry. Compounds are grouped in families according to their chemical structure. The complete
characterization of the extracts has been previously reported [18,20,37]. The common name of each
compound is included under its structure. Compounds with their names in red indicate that these
compounds have been identified as plasma metabolites in the bibliography.
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3. Characterization and Synergy of Hibiscus sabdariffa Bioactive Compounds
HS herbal tea has been traditionally consumed by various cultures. In the abovementioned
research studies, HS was generally prepared as a standardized aqueous extract from their dried calyces,
although other leaf extractions have also been used [39]. Complex plant-derived mixtures such as
herbal teas suppose an important challenge for analytical procedures, although the chromatographic
profile of HS aqueous extracts have been studied in detail [50]. In an attempt to identify the major
bioactive compounds, several studies have focused on the chemical characterization and quantitation of
extracts from HS calyces by high-performance liquid chromatography coupled to high resolution mass
spectrometry (HPLC-MS) [18,20,37]. These studies revealed that anthocyanins together with organic
acids are two of the most abundant groups identified in the aqueous extract [18] (Figure 1). However,
phenolic acid derivatives, flavonol derivatives and phenylpropanoids have also been identified and
quantified in the extract (Figure 1). HS calyces are rich in polysaccharides and soluble fiber, mainly
pectins, arabinans and arabinogalactans of low molecular mass [51], but it is proposed that these
compounds do not contribute to HS bioactivity [20]. HS calyces also contain a high concentration
of ascorbic, arachidic, citric, stearic, and malic acids [52], making its aqueous extract quite acidic
(pH = 2.8), which is ideal for maintaining polyphenolic stability. In addition, other biomolecules are
present in the aqueous extracts at a low percentage, mainly unidentified proteins and peptides [53].
Therefore, such a complex plant-derived mixture may represent an opportunity for the study of
potential synergistic effects on different pharmacological targets.
Plants have developed various strategies to modulate biological processes through molecular
promiscuity or polypharmacologic effects, which act as multi-target drugs [54]. Due to their nature,
plant bioactive compounds could have modulated their diversity throughout evolution to act as
ligands of different molecular targets in animal cells. This would be responsible for the enhancement
of therapies through possible synergistic interactions with multiple targets. This particular feature of
plant compounds could become an opportunity to design suitable and novel approaches for diseases
with complex pathogenic mechanisms [36], such as obesity-related complications.
Several studies have postulated on the putative synergistic effect of mixed botanical compounds
or extracts to explain their beneficial effects [41,55,56]. Nevertheless, only a few studies have
demonstrated the increased efficiency of HS extracts with respect to its isolated compounds, suggesting
a therapeutic advantage for the whole extract in the treatment of complex disorders [20]. Nevertheless,
it must be noted that the synergistic effect of botanical products is difficult to prove. Synergistic
pharmacological interactions between compounds or drugs must be demonstrated by using specific
experimental and mathematical approaches, such as the calculation of the combination index, the
fractional inhibitory concentration index or isobologram construction [10]. However, this is not always
easy to approach in the case of very complex matrices [57], since multiple combinations are implicated,
and in many cases the polyphenolic mixtures are not fully characterized [10,58].
Plant mixtures may also exhibit an inverted U-shaped dose-effect curve of purification level
vs. bioactivity, i.e., bioactivity increases up to a certain point in which the increase of the purity
leads to the loss of some important compound, with the concomitant drop in bioactivity. Therefore,
bioassay-guided isolation processes usually fail to reveal the major active compounds of a complex
mixture. An alternative to this problem could consist in testing the whole extract and its fractions
via metabolomics-guided isolation [59]. The integration of high content screening with non-targeted
metabolomics could provide an additional strategy to recognize the metabolites responsible for the
biological effects and facilitate the demonstration of the putative synergy in complex herbal mixtures.
4. Bioavailability, Tissue Distribution and Cellular Metabolites Derived from Hibiscus sabdariffa
Bioactive Compounds
Despite the considerable efforts to characterize the HS extract and the abundance of known
potential bioactive compounds, the identification of the key components and their potential targets
is still largely unknown. Understanding the pharmacokinetics of compounds derived from HS
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extracts is essential, since their absorption, metabolism and distribution might determine the mode
of action and molecular targets involved in its bioactivity. Regardless, despite the abundance of
anthocyanins in HS and their attributed beneficial effects on health, several studies have revealed that
these compounds present low absorption and bioavailability in vivo [60]. Therefore, it is possible that
other, less abundant compounds present in HS extracts or other not yet unidentified metabolites may be
responsible for the observed beneficial effects. In this respect, a bioavailability study carried out in rats
revealed a total of seventeen compounds in rat plasma samples, of which quercetin and kaempferol
glucuronides were the most predominant one [19]. In fact, recent studies have revealed a higher
bioavailability of flavonol derivatives derived from HS compared with other alternative sources [61],
with an approximate plasma concentration of 5 µM after administration in rats [19]. In this vein,
the metabolite quercetin-3-glucuronide (Figure 1) was detected in hepatic and immune cells in the liver
and in the intestinal mucosa of hyperlipidemic mice fed with a polyphenol-enriched extract of HS,
concomitantly with an improved steatohepatitis [21]. The permeability of the polyphenolic extracts in
Caco-2 intestinal human cells, a model of human intestinal absorption, has also been reported [50,62].
The data from these studies revealed a low level of permeability of the complex polyphenolic mixture
through the gut barrier, suggesting that the presence of high concentrations of several polyphenols
in the extract could lead to a saturation of the specific transport mechanism. In these studies, only a
few compounds (N-feruloyltyramine and quercetin (Figure 1), among others, were able to pass
through the gut barrier model. Finally, a recent study in hypertrophied 3T3-L1 adipocytes revealed
the cellular absorption and metabolism of both quercetin and quercetin-3-glucuronide in adipocytes,
which suggests that these flavonols might also reach other intracellular targets that contribute to
their bioactivity [63]. Given all this, it could be hypothesized that the compounds responsible for the
multiple effects observed with HS extracts may not be the most abundant ones, being the flavonol
derivatives the possible candidates for the observed effects in animal models.
5. Effect of Hibiscus sabdariffa Compounds on Selected Digestive Enzymes
Very few studies have focused on the interaction of HS polyphenols with digestive enzymes as
their putative molecular targets to explain their effect on obesity. Polyphenols are capable of interacting
with proteins through hydrophobic or hydrophilic interactions, leading to the formation of aggregates
that can alter and affect its biological activity [64]. The inhibitory effect of HS polyphenols against
enzymes implicated in carbohydrate digestion, such as α-amylase activity, and the ability of these
compounds to block sugars and starch absorption in an α-amylase-added Caco-2 system, has been
reported, which deserves further attention due to is potential implication in weight loss [65,66].
The potential inhibitory activity against pancreatic lipase was also reported by examining the effect
of HS extracts on fat absorption-excretion and body weight in rats [67]. This study concluded that
animals supplemented with HS polyphenols excreted significant amounts of fat in the feces, mainly
palmitic and oleic acids, compared to controls. In addition, the lower weight gain observed in HS-fed
animals leads to postulate on an inhibitory effect of pancreatic amylase, in agreement with that
proposed by Hansawasdi et al. Thus, continuous administration of HS polyphenols might improve
obesity-related metabolic disorders in a similar manner to current digestion inhibitory drugs such as
orlistat, which is also associated with triglyceride reductions and adiponectin activation [68]. Although
these studies considered hibiscus acid as the main component responsible for the enzymatic inhibition
(Figure 1), other recently identified HS compounds could also be responsible by inhibiting pancreatic
lipase and/or α-glucosidase. Unfortunately, little is known regarding the molecular mechanisms
implicated in the inhibition of these or other digestive enzymes by phenolic compounds. A plausible
hypothesis could be that these compounds interact directly with the catalytic site of the enzymes,
especially if the site is hydrophobic. In our laboratory, we performed molecular docking experiments
of a library containing all the compounds identified in HS extracts (Figure 1) against the catalytic
binding sites of different enzymes present in the digestive tract. To this end, the crystal structures
of pancreatic lipase and glucosidase enzymes were selected to determine whether HS polyphenols
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can bind these enzymes with sufficient affinity to be considered as inhibitors. Molecular docking
can predict the structure of a receptor-ligand complex and calculates a theoretical Gibbs free-energy
variation (∆G, kcal/mol) for different poses of each ligand. This parameter reflects the intensity and
number of atomic interactions between the amino acids of the binding site in the protein and the
ligand [69,70]. Figure 2 depicts the Gibbs free-energy variation values calculated through molecular
coupling experiments obtained using a library of compounds present in the HS (Figure 1) against
the catalytic site of various intestinal glucosidase enzymes (Figure 2A) as well as against two ligand
binding sites of the enzymatic complex of the pancreatic triacylglycerol lipase/colipase (Figure 2B).
As it can be observed in Figure 2A, the majority of the compounds exhibited lower or similar ∆G
values to compounds such as agarbose or naringenin [71], which are known inhibitors of intestinal
glycosidases. Therefore, flavonols such as quercetin or kaempferol and their metabolites (Figure 1),
which have been identified in plasma of treated animal models, could behave as competitive inhibitors
of these glucosidases. Likewise, some phenolic acids or anthocyanins may act as putative ligands
of intestinal glucosidase enzymes due to their reasonably low ∆G values. Similarly, the free energy
variations for the binding of the HS compounds to the two sites in the lipase/colipase complex
are shown in Figure 2B and compared to the drug inhibitor orlistat. As mentioned in the case of
intestinal glucosidases, the majority of the HS compounds exhibited lower ∆G values than this drug,
and therefore it is plausible to consider these compounds as inhibitors of this enzymatic complex,
which could account for the decreased absorption of fatty acids observed in animal models using HS
extract, especially for flavonols derivatives. Our computational results based on free-energy variations
suggest that these molecules have the potential to inhibit digestive enzymes. Nevertheless, further
in vitro and in vivo studies will be required to substantiate whether this in silico approach is an
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the precursor  of  the majority  of  the ROS produced,  and  can  lead  to  the  formation  of  hydrogen 
Figure 2. Comparison of the free energy variation (∆G, kcal/mol) of the Hibiscus sabdariffa bioactive
compounds and X-ray co-crystalized ligands or known modulators (first name of each panel and
yellow background) against the main binding sites of the catalytic binding site of some glucosidase
enzymes (panel A) and the two crystal binding sites of the triacylglycerol lipase/colipase complex
(panel B) by molecular docking. The common name of each compound is included under mean and
standard deviation plotted in each panel. Red colour names indicate that these compounds have been
identified as plasma metabolites in the bibliography. For the virtual screening process, a chemical
library containing the chemical structures to be screened was initially built, following ADMET criteria.
In addition, the molecular target high resolution structures were obtained. Then, computer clusters with
a high computation capability were used to compare target structures with the chemical library to find
the best docking results according to DG binding values. Finally, all tested compounds were prioritized
as a function of minor DG and proposed as candidates for subsequent in vitro and in vivo tests.
6. Molecular Effects of Hibiscus sabdariffa Polyphenols
6.1. Effect on Redox Homeostasis
The antioxidant capabilities of plant polyphenols have been well established by many in vitro
and in vivo studies, demonstrating a clear correlation with health [16]. To this end, botanical
polyphenols could be used as possible therapeutic sources to treat obesity. Oxidative stress is
implicated in the development of many chronic conditions, including obesity. This is due to an
imbalance between excess reactive oxygen species (ROS) and the inability of the intracellular defense
system to efficiently eliminate these oxidative agents. This dysregulation leads to the oxidation
and damage of macromolecules such as carbohydrates, lipids, proteins and nucleic acids, which
finally cause organelle and cell dysfunction and contributes to the progression of the pathology [72].
ROS are a set of unstable molecules and free radicals derived from molecular oxygen (O2) and are
mainly generated in the oxidative respiratory chain of the mitochondria. Superoxide anion (·O2−) is
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generally the precursor of the majority of the ROS produced, and can lead to the formation of hydrogen
peroxide (H2O2), and consequently hydroxyl radical (OH·) by Fenton’s reaction. Oxidative damage is
generally prevented through the release of intercellular and intracellular antioxidant enzymes such as
superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase
(GR), which act as scavengers for the different ROS (Figure 3) [73]. Additionally, ·O2- and H2O2
can also be generated by NADPH oxidase, a membrane-bound enzymatic complex, which plays an
important role in cellular proliferation, serotonin biosynthesis, endothelial signaling, regulation of
renal functions, and the immune response against microorganisms, although its overexpression is












Figure  3. Multiple  effects of HS polyphenols on  intracellular  redox homeostasis. The  antioxidant 
abilities of HS polyphenols (HSp), represented by colored hexagons, act directly or indirectly upon 
intracellular ROS generation in oxidative status. HSp may directly react with ROS and free radical 
intermediates  by  halting  the  chain  reaction,  thereby  stopping  the  ROS‐induced  damage.  HSp 
antioxidant activity blocks  intracellular ROS generation  in hydrophilic environments and also  the 
generation  of  lipoperoxy  radicals,  which  are  major  responsible  for  DNA  oxidative  damage. 
Alternatively, HSp may act  indirectly by up‐regulating antioxidant enzymes expression or protein 
activation. SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GR, glutathione 




with  an  increased NADPH  oxidase  expression  and decrease  in  antioxidant  enzymes  [75]. Other 
studies have reported that high levels of fatty acids and glucose increase intracellular ROS generation 




Figure 3. Multiple effects of HS polyphenols on intracellular redox homeostasis. The antioxidant
abilities of HS polyphenols ( Sp), represented by colored hexagons, act directly or indirectly
upon intracellular ROS generation in oxidative status. HSp may directly react with ROS and free
radical intermediates by halting the chain reaction, thereby stopping the ROS-induced damage.
HSp antioxidant activity blocks intracellular ROS generation in hydrophilic environments and also
the generation of lipoperoxy radicals, which are major responsible for DNA oxidative damage.
Alternatively, HSp may act indirectly by up-regulating antioxidant enzymes expression or protein
activation. SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GR, glutathione
reductase. Different colors of HSp symbols indicate different families or structural moieties of
polyphenols’ metabolites.
A correlation exist betwe n obesity an , as a chronic infla matory process
has been d tected in the adipose tissue f obese experimental animal models as well as in hum ns,
along with an incr ased NADPH oxidas expression and ecr antioxidant enzymes [75]. Other
studies have r ported that high lev ls of fatty acids and glucose increase intracellu ar ROS generation
in adipocyte cell cultures [20,75,76]. According to thes reports, adipocytes in obes individuals
undergo hypertrophy as a result of an excess caloric intake and a low metabolic rate. Consequently,
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the increased expression of NADPH oxidase, exacerbated fatty acid oxidation in the mitochondria,
and decreased expression of SOD, CAT and GPx lead to an excessive production of ROS. ROS also
function as mediators for the activation of nuclear factor-κB (NF-κB) and mitogen-activated protein
kinase (MAPK), contributing to the dysregulation of the expression of inflammatory adipokines and a







Figure  4.  Effects  of  HS  polyphenols  on  inflammation‐related  and  MAPK  pathways.  Cellular 
inhibitory effect of HS polyphenols  (HSp),  represented by  colored hexagons,  is associated with a 
decreased phosphorylation of extracellular signal‐regulated protein kinases 1 and 2 (ERK1/2) and c‐
Jun N‐terminal kinases  (JNK), as well as p38 kinase. HS polyphenols also  inhibit  inflammation by 
down‐regulating NF‐κB pathway and ROS generation, revealing that inflammation, oxidative stress‐
related pathways and mitochondrial function are closely related and interdependent processes in the 
HSp  effects. Different  colors  of HSp  symbols  indicate different  families  or  structural moieties  of 
polyphenols’ metabolites. 
Various studies have indicated a possible role for HS polyphenols in regulating excess ROS in 
obesity‐related  disorders.  For  example, HS  aqueous  extracts  have  shown  a  higher  capability  to 









combination  of  bioactive HS  polyphenols  could  represent  an  opportunity  to  ameliorate  obesity‐
associated oxidative stress. 
A correlation between the total phenolic content of HS extracts and their antioxidant properties 
has been  reported  [20,78]. Therefore,  it must be presumed  that  the  antioxidant properties of  the 
extracts lie on the polyphenol´s abilities (phenolic acids, flavonols and anthocyanins) to scavenge free 
radicals.  This  effect  has  been  observed  in  several  oxidative  damage models,  in  both  cells  and 
Figure 4. Effects of HS polyphenols on inflammation-related and MAPK pathways. Cellular
inhibitory effect of HS polyphenols (HSp), represented by colored hexagons, is associated with a
decreased phosphorylation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and
c-Jun N-terminal kinases (JNK), as well as p38 kinase. HS polyphenols also inhibit inflammation
by down-regulating NF-κB pathway and ROS generation, revealing that inflammation, oxidative
stress-related pathways and mitochondrial function are closely related and interdependent processes
in the HSp effects. Different colors of HSp symbols indicate different families or structural moieties of
polyphenols’ metabolites.
Various studies have indicated a pos ible role for S l l cess R S
in obesity-related disorders. For le, extracts have shown a higher capability to
scavenge peroxyl radicals in water environments than in lipophilic sy tems, as well as a stronger
metal-reducing effect han olive leaf . The antioxidant properties of HS polyphenols
have also been measured in the plasma of rats after an acute i gestion of a p lyphenol-enriched
HS extract [19]. In a l ter study, a correlation betw en the pr sen e of phenolic acids in plasma
at shorter times and its antioxidant e fect through ferric io red ction and sup roxide scavenging
was eported. Furthermor , the presence of flavonol glucuro ides (quercetin and k e pferol) in
plasma samples at long r times correlated with an inhibitory effect on lipid peroxidati n. Furthermore,
a polyphenol-enriched HS extract exerted a higher effect on inhibiting intracellular ROS formation
than an aqueous HS extract in a culture of hypertrophied adipocytes [20]. All these ata suggest
that finding a suitable ombination of bioactive HS polyphenols c uld epresent an oppor unity to
amelior te obesity-associated oxidative stress.
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A correlation between the total phenolic content of HS extracts and their antioxidant properties
has been reported [20,78]. Therefore, it must be presumed that the antioxidant properties of the extracts
lie on the polyphenol´s abilities (phenolic acids, flavonols and anthocyanins) to scavenge free radicals.
This effect has been observed in several oxidative damage models, in both cells and experimental
animals. The organic extracts from HS exhibited strong protective properties against malondialdehyde
formation and cellular lysis in tert-butyl hydroperoxide-induced oxidative damage in rat primary
hepatocytes, suggesting a protective effect against cytotoxicity and genotoxicity [79]. HS anthocyanin
extracts have been shown in vitro to scavenge O2- radicals and H2O2, completely attenuate the
CCl(4)-mediated decrease in antioxidant enzymes, as well as activate phase II drug detoxification
enzymes in CCl(4)-induced oxidative damage of rat livers [80]. Furthermore, the antimutagenic activity
and free radical scavenging effects on active oxygen species and lipid peroxidation of HS organic
extracts (chloroform and ethyl acetate) has been reported using an oxidative stress-induced rat model,
besides revealing a strong ability to scavenge ·O2- and OH· radicals and H2O2 in vitro [81]. These
results point to a strong scavenging ability of HS polyphenols at different stages by eliminating ·O2-,
H2O2 and OH·, which may take place either by simple hydrogen donation or by preventing antioxidant
enzyme degradation. Furthermore, the capacity of HS polyphenols to inhibit lipid peroxidation
evidenced in different models may be related to their ability to scavenge OH· radicals, which are the
major culprits for the generation of lipoperoxyl radicals (ROO·) (Figure 3).
As mentioned above, polyphenols from HS may not only exert their antioxidant effect by directly
scavenging ROS, but also by modulating their effect and induce the expression of other antioxidant
enzymes. Essa et al. [82] reported that HS extracts increased the levels of SOD, CAT and GPx,
and reduce glutathione (GSH) in brain tissues of hyperammonemic rats. In addition, several studies
in animal models of metabolic syndrome, diabetes or hyperlipidemia have reported an increase in
the expression of SOD, CAT, GPx and GR (Figure 3) in several tissues, such as the kidney, liver and
heart [83–87]. These studies support the hypothesis that HS extracts are capable of ameliorating
oxidative stress in metabolic diseases.
6.2. Hibiscus sabdariffa Effects on Inflammatory and Immune Response
Adipose tissue represents not only a metabolic but also an important endocrine organ. Adipocytes
are the main constituent cells in this tissue, and their primary function is to store energy as fat.
Nevertheless, adipocytes also play an important role in the secretion of a large number of hormones
and cytokines (adipokines) that regulate processes such as lipid metabolism, glucose homeostasis,
insulin sensitivity, inflammation, blood pressure or angiogenesis. In addition to adipocytes, other cells
such as fibroblasts, pre-adipocytes, vascular endothelial cells and immune cells are also present in the
adipose tissue.
In an obese individual, the adipocytes are hypertrophic, leading to molecular and cellular
disturbances that can affect their functionality [88]. Accordingly, the secretion of pro-inflammatory
adipokines increases in this tissue, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α),
monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1)
(Figure 4). This pro-inflammatory phenotype leads to a low-grade inflammation systemic condition
including macrophage infiltration in adipose tissue [88,89]. Furthermore, lipid accumulation in other
organs such as the muscle, pancreas or liver can induce inflammation and insulin resistance, as well as
develop metabolic diseases such as liver steatosis, atherosclerosis or type 2 diabetes [1,90,91]. On the
other hand, chronic inflammation and oxidative stress are closely related and interdependent processes
that contribute to the pathogenesis of obesity-associated diseases [92].
The anti-inflammatory activity of HS polyphenols has been previously reported in cell and animal
models and humans. For example, in the cell model of hypertrophied 3T3-L1 adipocytes, both aqueous
and polyphenol-enriched HS extracts inhibited the secretion of eight pro-inflammatory adipokines [20].
Ameliorating the oxidative status might be one of the strategies by which HS polyphenols exert
their anti-inflammatory effects, since oxidation and inflammation are closely associated. In this regard,
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the HS polyphenolic extract has been found to inhibit xanthine oxidase activity in vitro, and decrease
nitrite and prostaglandin E2 secretions in LPS-induced cells. Moreover, HS polyphenols also inhibited
inflammation by down-regulating cyclooxygenase-2 (COX-2) and inhibiting the activation of c-Jun
N-terminal kinase (JNK) and p38 kinase, postulating a relationship between HS polyphenols, oxidative
stress and suppression of nuclear factor-κB (NF-kB) translocation in a lipopolysaccharide-induced
inflammation rat model (Figure 4) [93].
The production of MCP-1 in monocytes/macrophages can be mediated through the activation of
extracellular signal-regulated kinases 1/2 (ERK1/2) and JNK as well as the NF-κB pathway [94]. NF-κB
is a complex protein capable of regulating the transcription of several genes related to the inflammatory
process. HS extracts have been demonstrated to inhibit the expression of NF-κB, as well as decrease
the levels of TNF-α, IL-6 and IFN-γ, indicating a hepatoprotective effect in rats with thioacetamide
(TAA)-induced hepatotoxicity [49] (Figure 4). Furthermore, oral consumption of an aqueous HS extract
in healthy humans has been shown to decrease the plasma levels of MCP-1, suggesting that such
an effect is not due to the antioxidant activity itself, but rather the inhibition of inflammatory and
metabolic pathways [17].
Since oxidative stress, inflammation and hypertension are also closely linked, the relationship
between HS consumption and blood pressure has been investigated by several authors. Joven et al.
demonstrated that HS extracts lowered blood pressure in human patients with metabolic syndrome and
improved the endothelial function in a rat model. In this study, the consumption of 125 mg/kg/day
of HS polyphenols by human patients for four weeks decreased the majority of the inflammatory
and oxidative stress biomarkers analyzed, as well as increased the anti-inflammatory hormone
adiponectin [22]. The same study revealed that HS extracts reduced the blood pressure in rats,
while also inhibiting TNF-α-induced cytokine secretion in rat endothelial cells, suggesting a
possible transcriptional down-regulation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Furthermore, a reduction of NF-κB and ROS generation and increased nitric oxide synthase (eNOS)
and nitric oxide (NO) was observed in the same cells. The results of this study suggest that the
hypotensive effect of HS extracts observed in both humans and rats might be mediated by antioxidant,
anti-inflammatory and endothelium-dependent mechanisms, in agreement with Hopkins et al. [95].
However, this is in contrast with other studies that have attempted to explain the antihypertensive
effectiveness of this extract only through the inhibition of the angiotensin I-converting enzyme [96,97].
In this regard, a recent meta-analysis study on randomized controlled trials using HS confirmed the
potential effectiveness, reducing both systolic and diastolic pressure and considered the combination
of HS supplements and antihypertensive medications to optimize the antihypertensive therapy [38].
All this evidence leads to the postulation that the anti-inflammatory effects of HS polyphenols
are closely related to the modulation of oxidative stress-related pathways. Nevertheless, it must
be assumed that the complex mixture of compounds contained in the polyphenolic HS extract
may interact with a wide variety of molecular targets directly related to inflammatory processes;
therefore, the modulation of gene expression and/or protein activity in these pathways should also be
considered. Anyway, the inhibition of MAPK and NF-kB pathways seem to be the major mechanisms
of action of HS polyphenols (Figure 4). Thus, regulation of the inflammatory processes in obesity
through HS extract consumption could be an interesting approach to ameliorate and/or prevent other
chronic inflammatory diseases related to metabolic syndrome such as atherosclerosis, steatohepatitis
or cardiovascular diseases.
6.3. Modulation of Energy Metabolism and Lipid Management by Hibiscus sabdariffa Polyphenols
Polyphenols comprise of a number of molecular scaffolds with an enormous variety of
substitutions with different moieties, either through intermolecular interactions or by polymerization.
Therefore, it seems reasonable to consider that such a structural diversity confers the possibility
of generating a limitless number of pharmacological compounds for various targets. In this sense,
complex polyphenolic mixtures may have a multi-targeted mechanism of action, as reported [10].
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As previously commented the different chemical structures contained in the HS extract (Figure 1)
have a strong antioxidant capability and protect against chronic inflammation, which have been
positively correlated to obesity-related metabolic disorders [48,98]. Nevertheless, these pathologies
are complex conditions that require a multifaceted approach, including effects on the inflammatory
network, antioxidant status and energy metabolism. Recently, the relationship between polyphenols
interactions and energy metabolism modulation has been reported, suggesting that the consumption
of plant-derived polyphenols can change lipid and energy metabolism and may facilitate weight loss
and prevent weight gain [15].
The ability of HS polyphenols to modulate energy metabolism in order to explain the potential
beneficial effects on lipid management and weight loss has been studied by several authors in cell
and animal models. The polyphenol-enriched HS extract presented a higher efficiency in inhibiting
intracellular triglyceride accumulation than aqueous HS extract that contained higher polysaccharide
content in a culture of hypertrophied adipocytes [20]. This observation points to the polyphenols as the
candidate molecules responsible for the lower lipid accumulation, indicating that it may be a suitable
strategy to improve obesity-associated disturbances. Several studies have proven the ability of HS
polyphenols to help reduce body weight through inhibition of fat accumulation, while also improving
glucose tolerance and normalize the glycemic index in obese mice models [23,99].
Its effect on weight loss has prompted hibiscus extract to be examined for its potential effect on
lipid profiles. Several studies have indicated that HS extracts have a lipid lowering activity, which could
prevent cardiovascular disease through lipid modification [100]. Fernández-Arroyo et al. [18] tested
HS polyphenols on low density lipoprotein receptor deficient mice (LDLr−/−) under a hypercaloric
diet (20% fat and 0.25% cholesterol, w/w). A strong correlation between HS consumption and the
ability to decrease serum triglyceride concentration was reported in this study. Several studies using
hyperlipidemic rat models together with continuous cholesterol feeding for four weeks resulted in
a significant reduction of serum cholesterol, triglycerides, LDL and VLDL levels [101,102]. Since the
majority of the plasma apolipoproteins, endogenous lipids and lipoproteins are synthetized in the
liver, several studies have attempted to establish a link between the hypolipidemic ability of HS and
its putative mechanism on the liver. Yang et al. [24] examined the effect of HS on liver fat metabolism
and revealed that HS polyphenols reduced liver damage by promoting lipid clearance. A decrease in
the plasma lipid level and hepatocyte lipid content concomitantly with the activation of AMPK, along
with an inhibition of fatty acid synthase (FASN) expression, was also detected. A similar effect has
been observed in hyperlipidemic mice model, in which the administration of the HS polyphenolic
extract prevented fatty liver disease associated with changes in lipid and glucose metabolism, as well
as AMPK activation and decreased expression of lipogenic genes such as FAS and SREBP-1c [21]
(Figure 5).
It is known that the activation of AMPK, a master regulator of energy metabolism, and the
subsequent inhibition of acetyl-CoA carboxylase play a crucial role in fatty acid oxidation by regulating
mitochondrial availability of fatty acids [103] (Figure 5). Both AMPK and PPARs have been shown
to play an important role in the pathogenesis of both alcoholic liver disease and non-alcoholic fatty
liver disease, in which fatty acid oxidation is impaired. Administration of AMPK or PPAR-α activators
have shown to be effective in ameliorating both diseases [104]. Polyphenols have also been shown to
upregulate PPAR-γ-mediated adiponectin expression, along with AMPK activation [12]. Therefore,
regulating the complex network of energy metabolism and mitochondrial function may require a
multifaceted approach, including AMPK and PPARs, which can be addressed by the pleiotropic
character of plant-derived polyphenols.
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Figure 5. Pleiotropic effects of HS polyphenols on cellular energy metabolism and lipid and glucose
homeostasis. HS polyphenols (HSp), represented by colored hexagons, stimulate AMP-activated
protein kinase and, consequently, inhibit downstream targets, such as acetyl-CoA carboxylase (ACC)
and fatty acid synthase (FASN), decreasing the fatty acids synthesis and stimulating lipolysis.
Alternatively, HSp action, either directly or through AMPK, promotes downregulation of FASN
by the inhibition of the sterol regulatory element-binding protein-1c (SREBP-1c). The modulation of
peroxisome proliferator-activated receptors (PPAR) expression and/or activity, and the subsequent
adiponectin expression increase, in response to HSp improves lipid and glucose homeostasis and
mitochondrial biogenesis. The pleiotropic effects of HSp also include primary control mechanisms
such as epigenetic modifications through histone acetylation, DNA methylation and miRNA
expression. Different colors of HSp symbols indicate different families or structural moieties of
polyphenols’ metabolites.
HS polyphenols have been proven to regulate AMPK as well as several transcription factors related
to lipid and glucose homeostasis, such as PPARs and SREBP-1c in hyperlipidemic mice model [21,23]
(Figure 5). Growing evidence indicates that these transcription factors are critical regulators of hepatic
lipid metabolism, stimulating the expression of several enzymes implicated in liver fatty-acid synthesis,
glucose transport and gluconeogenesis [23]. Consistent with this hypothesis, a recently discovered
low molecular weight compound acting as an adiponectin receptor (AdipoR) agonist, AdipoRon,
has been proposed as a possible molecular tool to improve insulin resistance, by mediating the
activation of AMPK and PPAR-pathways, mimicking the effect of adiponectin [3]. Thiazolidinediones
are oral medications for type 2 diabetes that function as synthetic ligands and potent agonists of
PPAR-γ, being highly effective in reducing glucose levels and improving insulin sensitivity. However,
the administration of thiazolidineones is associated with the occurrence of severe side effects such
as fluid retention, weight gain, cardiac hypertrophy, bone fractures and hepatotoxicity (Figure 5) [6].
The use of polyphenols as mild PPAR-γ agonists based on selective cofactor-receptor interactions,
while avoiding the side effects observed in synthetic agonists, has been postulated as an opportunity for
the management of obesity [69]. In fact, some polyphenols such as resveratrol [105] or scutellarin [106]
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have shown experimentally the capability to modulate PPAR-γ. Moreover, extensive effort has been
recently made on the design of alternative synthetic PPAR modulators, such as metaglidasen, that are
devoid of the typical side effects observed with thiazolidinedione anti-diabetic agents [107]. The ability
of HS polyphenolic extracts to activate AMPK has also been associated with the activation of PPAR-α,
which triggers FASN inhibition, stimulating fatty acid oxidation and antioxidant enzyme expression,
thereby reducing lipid content and oxidative stress, which enhance mitochondrial metabolism and
lipid management [21] (Figure 5). HS polyphenols has also been correlated with a significant increase
in serum adiponectin and decrease in serum leptin, which can revert overweight-induced metabolic
alterations [22].
6.4. Epigenetic Effects of Hibiscus sabdariffa Polyphenols
The majority of the studies on the effects of HS and other plant polyphenols have focused
on specific molecular targets in order to explain their molecular mechanism in the amelioration of
obesity-related pathologies. As such, several cellular pathways, transcription factors and enzymatic
activities seem to be modulated by these compounds. This mode of action suggests the existence of a
primary control mechanism, which appears to be in line with the pleiotropic character and structural
diversity of these compounds. Recent studies have shown that plant polyphenols are capable of
exerting an epigenetic control. Epigenetics include a number of extra-genetic processes such as DNA
methylation, post-translational histone modifications and non-coding RNA mediated gene silencing,
all of which can alter gene expression, but do not involve DNA sequence changes and can be modified
by environmental stimuli [108]. Plant derived polyphenols, such as curcumin, catechins, resveratrol or
some flavonols, can interact with various enzymes and important epigenetic modifiers, such as histone
acetyltransferases, histone deacetylases, DNA methyltransferases, kinases and miRNA [109,110].
Several authors have reported that polyphenols can reverse the altered epigenetic modifications
observed in metabolic disorders by changing DNA methylation and histone modifications [111].
For example, polyphenols are effective histone deacetylases inhibitors and thus can be used to reverse
the reduced histone acetylation associated with neurodegeneration [112,113]. Quercetin, a fairly
abundant flavonol in the polyphenolic fraction of HS extracts, inhibited the histone acetyltransferase
activity in the promoter region of genes associated with inflammation [114]. Currently, the epigenetic
regulation of energy balance and adipose tissue biology has been proposed by modulating the
expression of certain microRNAs [115]. HS polyphenols have been shown to be capable of regulating
microRNA expression in hyperlipidemic mice with LDL receptor deficiency [21]. The chronic oral
administration of HS polyphenols in mice under a fat-enriched diet reverted the changes observed in
non-specific microRNAs miR103/107 concomitantly with the prevention of diet-induced fatty liver
disease and changes in lipid and glucose metabolism (Figure 5). Recently, the ability of HS polyphenols
to regulate gene expression through the epigenome has been confirmed [116]. Research is currently
focused on elucidating whether HS polyphenols and their metabolites are capable of regulating
epigenetic modifications through DNA methylation, histone post-translational modifications of miRNA
expression modulation.
7. Virtual Screening of Hibiscus sabdariffa Polyphenols on Selected Protein Targets
Many studies have indicated that HS polyphenols are capable of targeting several proteins that are
implicated in obesity-associated metabolic disorders, i.e. AMPK, PPAR and FASN. In order to elucidate
on the possibility that HS polyphenols may exert a direct effect on these proteins, virtual screening
using a library of chemical structures was assessed (Figure 1). The abundant high resolution structural
information of these proteins, especially for PPAR and AMPK, allowed us to perform molecular
docking approaches in order to try to understand if HS compounds, especially those detected in blood
plasma as metabolites, could interact with these proteins at their catalytic or regulatory sites. The results
are shown in Figure 6A (AMPK kinase) and Figure 6B (fatty acid synthase and PPARgamma). AMPK
is a cellular energy state-sensitive kinase that is activated under deficient energy states due to lack of
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nutrients or hypoxia [117]. In addition, it can be activated when certain proteins are phosphorylated,
promoting the inactivation of energy-consuming pathways and activating the catabolism of fatty acids
and other fuels [118]. The AMPK gamma subunit has three binding sites for AMP/ADP or other
modulators, which activate and maintain the phosphorylation of threonine 172 within the activation
loop of the catalytic alpha subunit kinase. Here, we have performed molecular docking with the x-ray
co-crystallographic ligands and AMPK subunits on its binding sites as a control of the most adequate
∆G in each binding site. X-ray value for AICAR as ligand on the three sites of the AMPK gamma
subunit presented a ∆G ≈ −6.5 ± 0.5 kcal/mol when docked over its respective binding sites for all
the available PDBs: 2UV4, 2UV5, 2UV6, 2UV7, 4CFE, 4CFF, 4RER, 4REW, and 4ZHX [118]. As can
be observed in Figure 6A, with the exception of hibiscus acid and its derivatives, all HS compounds,
especially those present in rat blood plasma as metabolites (its most commonly-used name is indicated
in red text, Figure 1), show ∆Gs decrease up to 2 kcal/mol compared to the controls included in the
graph, AICAR in this case. Therefore, these results seem to indicate that most HS compounds excluding
organic acids might act as potential activators for the AMPK gamma subunit. At the interface of the
interaction between the alpha catalytic and beta regulatory subunits of AMPK, crystallographic data
show an additional regulatory site for this enzyme. Molecular docking of the A-769662 activator against
this regulatory site presents a ∆G ≈ −10.72 ± 0.30 kcal/mol [118]. Our docking data against this
regulatory site shows that HS compounds exhibit ∆G values 2 kcal/mol greater than A-769662 inhibitor;
therefore, we would not expect them to exert any regulatory role on this binding site. When the ∆G
values of the HS compounds against the catalytic site of the AMPK alpha subunit were compared with
the ∆G value (−13.5 ± 1.3 kcal/mol) of staurosporine, which is an ATP-competitive kinase inhibitor
with a high affinity but little selectivity, it was observed that none of the HS compounds presented such
low ∆Gs values. As such, they would not behave as competitive AMPK inhibitors. Finally, Figure 6B
compares the ∆Gs of HS compounds with those of known PPARgamma and FASN modulators
or inhibitors. Only certain HS compounds (Kaempferol-3-O-rutinoside, quercetin-3-rutinoside or
tetra-O-methyljeediflavanone) presented a ∆G comparable to that of scutellarine, a flavone for which
there is experimental evidence [106] of its ability to bind to PPARgamma and thus could activate this
nuclear receptor. Interestingly, these same three compounds, and also quercetin 3,7-diglucuronide
showed a ∆G lower than −10 kcal/mol for FASN docking, which is comparable to that detected in
the GSK2194069 FASN inhibitor [119], making us to think that they could also behave as inhibitors of
this enzyme implicated in fatty acid biosynthesis. Taken together, the data derived from the molecular
docking experiments of HS compounds versus several binding sites to different proteins involved in
energy metabolism, seem to indicate that several compounds extracted from this plant might exert a
direct effect on these proteins. Of course, further studies, both in vitro and in vivo, will be required to
corroborate this hypothesis and understand the mechanisms by which these compounds exert their
effect on the corresponding proteins.
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Figure 6. Comparison of the free energy variation (∆G, kcal/mol) of the Hibiscus sabdariffa bioactive
compounds and X-ray co-crystalized ligands or known modulators (first name of each panel and
yellow background) against the main binding sites of: the catalytic binding site of the three AMPK
subunits obtained (A); and the catalytic binding site for fatty acid synthase and binding cavity of
PPAR-gamma nuclear receptor (B), by molecular docking. The common name of each compound is
included under mean and standard deviation plotted in each all four panel. Red color names indicate
that these compounds have been identified as plasma metabolites in the bibliography. Virtual screening
process was performed as mentioned in Figure 2.
8. Potential Molecular Mechanism of Hibiscus sabdariffa in Obesity: A Global Analysis
Obesity-related metabolic disorders are characterized by early cellular events and dysregulation of
normal cellular homeostasis. In this sense, obesity must be understood as a multidimensional disease,
ranging from adipocyte hypertrophy to the appearance of symptoms related to metabolic alterations.
HS derived polyphenols could approach the therapy of this pathology from a global perspective, taking
advantage of the pleiotropic character of these compounds. Several altered metabolic biomarkers and
proteins have been validated as a prequel in the development of bioenergy alterations. Thus, crucial
proteins such as PPAR, FASN, lipase, adiponectin, leptin, MCP-1, AMPK, NF-kB and SOD, among
others, have been proposed by several authors as specific targets in the treatment of obesity-associated
metabolic disorders. In this scenario, HS polyphenols seem to interact with all the above-mentioned
targets. In addition, their antioxidant capacity may explain many of the benefits granted to this plant.
Among the putative processes involved in the molecular effects of HS polyphenols on obesity
are: modulation of the signaling and energy metabolism pathways, regulation of redox homeostasis
and inflammation, restoration of mitochondrial functionality and epigenetic machinery regulation.
The last process may probably play a key role on the other aspects.
The extensive literature on the multiple beneficial effects that HS extract exert on obesity-related
diseases, as well as its putative mechanism of action, provides sufficient evidence to conclude that the
use of this extract could become an adjuvant in these pathologies. Despite the fact that the majority
of the cellular and animal effects observed with HS polyphenols have been corroborated in various
human trials, further studies are required to define the adequate dosage for therapy as well as validate
its use in the management of obesity [116]. Therefore, future research should pay attention to identify
the cellular metabolites of HS acting as final effectors through in vivo experiments and powerful
analytical platforms.
In this regard, a recent study on the acute multifunctional effects of HS polyphenols in humans
have used a combined transcriptomics and metabolomics approach to determine the modifications in
the expression of relevant genes through network-based methods [53]. Their results suggest that these
polyphenols exert simultaneous effects in mitochondrial function, energy homeostasis, oxidative stress
and inflammation, as well as cardiovascular-protective effects, acting upon multiple targets: proteins,
hormones and physiological peptides. These findings support the hypothesis that polyphenols are
extremely bioactive in humans, and the observed effects are the result of numerous beneficial and
synergistic interactions, through the modulation of multiple metabolic pathways and epigenetic
regulation [53].
Although the potential pharmacological and therapeutic superiority of the combination of
polyphenols in HS extract with respect to their individual components for obesity-related pathologies
seems to be demonstrated, several issues related to bioavailability, dosage and safety need to be
addressed before its use in human nutrition. First, human equivalent dose must be established
from animal trials to assure its efficacy in metabolic disorders. Second, the stability and absorption
of these formulations has to be explored to maximize the efficacy of these formulations in human
nutrition [10,20]. Finally, although the combination of polyphenols from HS appears to be safe from its
traditional use in several cultures, the subchronic administration of these mixtures has to be assayed
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for toxicity due to the potential polyphenol toxicity itself on a long-term basis or to the presence of
some contaminants in plants (mycotoxins, pesticides or metals) [120].
When explaining the multi-targeted effects that plant-derived polyphenols have on proteins
targets, an intriguing question arises: are we facing a large variety of molecules bearing a few moieties
able to interact with many protein targets, or are the responsible compounds just a few simple and yet
to be identified metabolites derived from many polyphenolic structures and acting at primary control
epigenetic mechanisms?
Nevertheless, the use of partial or biased approaches focused on specific targets will probably fail
to elucidate the precise mechanism of the polyphenols. On the contrary, to fully understand the health
and multi-target effects that polyphenols have on obesity and human health, it is necessary to integrate
transcriptomic, proteomic and targeted metabolomic approaches, with the support of virtual screening
techniques of metabolites on selected protein targets. Lastly, the use of epigenetic approaches will
be required to understand how these effects are regulated, as well as determine the most adequate
biomarkers for disease diagnostics and prognostics, as well as for treatment. Only with this global
approach we will be able to succeed in the design of polyphenolic mixtures sufficiently effective to
ameliorate obesity-related pathologies through nutritional intervention or pharmacological treatment.
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